Pasithea Therapeutics Corp. — All Filings
303 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFC14A
DEL AM
DFAN14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-26-021537 | Feb 27, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-018874 | Feb 20, 2026 | — |
| SCHEDULE 13G/A | — | 0002050709-26-000003 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001649553-26-000028 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-000884 | Feb 12, 2026 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-26-010202 | Jan 30, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-008828 | Jan 28, 2026 | — |
| EFFECT | — | 9999999995-26-000309 | Jan 27, 2026 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | 0001213900-26-007469 | Jan 26, 2026 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-126111 | Dec 29, 2025 | Jan 28, 2026 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-123883 | Dec 19, 2025 | Jan 28, 2026 |
| 8-K | CURRENT REPORT | 0001213900-25-121466 | Dec 15, 2025 | Dec 12, 2025 |
| SCHEDULE 13G | — | 0001213900-25-118701 | Dec 5, 2025 | — |
| SCHEDULE 13G | — | 0002050709-25-000011 | Dec 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-116985 | Dec 2, 2025 | Nov 28, 2025 |
| 4 | — | 0001213900-25-116296 | Dec 1, 2025 | Nov 28, 2025 |
| 4 | — | 0001213900-25-116309 | Dec 1, 2025 | Nov 28, 2025 |
| 424B4 | PROSPECTUS | 0001213900-25-116286 | Dec 1, 2025 | — |
| 4 | — | 0001213900-25-116299 | Dec 1, 2025 | Nov 28, 2025 |
| 4 | — | 0001213900-25-116301 | Dec 1, 2025 | Nov 28, 2025 |
| 4 | — | 0001213900-25-116306 | Dec 1, 2025 | Nov 28, 2025 |
| EFFECT | — | 9999999995-25-003424 | Nov 28, 2025 | — |
| S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-115595 | Nov 26, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-114763 | Nov 25, 2025 | Nov 20, 2025 |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-111842 | Nov 18, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-110093 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-105599 | Nov 4, 2025 | — |
| 4 | — | 0001213900-25-102677 | Oct 27, 2025 | Oct 24, 2025 |
| 4 | — | 0001213900-25-102680 | Oct 27, 2025 | Oct 24, 2025 |
| 4 | — | 0001213900-25-102681 | Oct 27, 2025 | Oct 24, 2025 |
| 4 | — | 0001213900-25-102682 | Oct 27, 2025 | Oct 24, 2025 |
| 4 | — | 0001213900-25-102676 | Oct 27, 2025 | Oct 24, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-102673 | Oct 27, 2025 | Oct 24, 2025 |
| 4 | — | 0001213900-25-102674 | Oct 27, 2025 | Oct 24, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-087903 | Sep 16, 2025 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-086184 | Sep 9, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-084062 | Sep 3, 2025 | — |
| DRS | — | 0001213900-25-081274 | Aug 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000157 | Aug 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-076557 | Aug 14, 2025 | Jun 30, 2025 |
| ARS | ARS | 0001213900-25-067350 | Jul 24, 2025 | Dec 31, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-067344 | Jul 24, 2025 | Sep 3, 2025 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-063716 | Jul 14, 2025 | Sep 3, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-063277 | Jul 11, 2025 | Jul 10, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-059004 | Jun 27, 2025 | Jun 23, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-056209 | Jun 20, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-056197 | Jun 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002281 | May 15, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-044281 | May 15, 2025 | Mar 31, 2025 |
| 144 | — | 0001213900-25-043622 | May 14, 2025 | — |